share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities- PFIZER INC

Pfizer | 4: Statement of changes in beneficial ownership of securities- PFIZER INC

辉瑞 | 4:持股变动声明- PFIZER INC
美股SEC公告 ·  08/05 18:27
Moomoo AI 已提取核心信息
Pfizer Inc, formerly a 10% owner of Cerevel Therapeutics Holdings, Inc. [CERE], completed a significant transaction by selling all of its holdings in the company. The sale consisted of 27,349,211 shares of common stock on August 1, 2024, at a price of $45.00 per share. This transaction resulted in a total market value of $1,230,714,495. Following this transaction, Pfizer Inc no longer holds any shares in Cerevel Therapeutics. The sale marks the end of Pfizer's direct ownership stake in the company.
Pfizer Inc, formerly a 10% owner of Cerevel Therapeutics Holdings, Inc. [CERE], completed a significant transaction by selling all of its holdings in the company. The sale consisted of 27,349,211 shares of common stock on August 1, 2024, at a price of $45.00 per share. This transaction resulted in a total market value of $1,230,714,495. Following this transaction, Pfizer Inc no longer holds any shares in Cerevel Therapeutics. The sale marks the end of Pfizer's direct ownership stake in the company.
辉瑞公司(Pfizer Inc)曾是Cerevel Therapeutics Holdings Inc [CERE]的10%股东,通过出售该公司的所有持股来完成了一项重大交易。该出售包括在2024年8月1日以45.00美元的价格出售了27,349,211股普通股。此交易导致总市值为1,230,714,495美元。在此交易后,辉瑞公司不再持有Cerevel Therapeutics的任何股份。这次出售标志着辉瑞公司对该公司的直接所有权份额的结束。
辉瑞公司(Pfizer Inc)曾是Cerevel Therapeutics Holdings Inc [CERE]的10%股东,通过出售该公司的所有持股来完成了一项重大交易。该出售包括在2024年8月1日以45.00美元的价格出售了27,349,211股普通股。此交易导致总市值为1,230,714,495美元。在此交易后,辉瑞公司不再持有Cerevel Therapeutics的任何股份。这次出售标志着辉瑞公司对该公司的直接所有权份额的结束。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息